Lessons learned from a cluster of immunization errors in newborns.

Q2 Medicine
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2024-01-02 eCollection Date: 2024-01-01 DOI:10.1177/25151355231221009
Loubna Alj, Amina Tebaa, Ismail Talibi, Sofia Moubarik, Mohammed Benazzouz, Rachida Soulaymani Bencheikh
{"title":"Lessons learned from a cluster of immunization errors in newborns.","authors":"Loubna Alj, Amina Tebaa, Ismail Talibi, Sofia Moubarik, Mohammed Benazzouz, Rachida Soulaymani Bencheikh","doi":"10.1177/25151355231221009","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vaccines are safe and effective, but adverse reactions can occur. Immunization errors (IEs) are one of the types of adverse events following immunization. The Moroccan Pharmacovigilance Centre (MPC) received a cluster of IEs from a maternity university hospital (MUH) regarding six newborns who were inadvertently administered rocuronium instead of hepatitis B (HepB) vaccine. The newborns experienced respiratory distress and one had a fatal outcome.</p><p><strong>Objectives: </strong>The study aimed to describe the investigation findings, the underlying causes, and contributing factors of the IEs cluster, and proposed risk minimization actions.</p><p><strong>Design: </strong>We carried out a descriptive analysis of the cluster of IEs related to the HepB vaccine reported to the MPC.</p><p><strong>Methods: </strong>An investigation was conducted by the Ministry of Health according to the World Health Organization guidance. The root cause analysis was performed to identify underlying causes and contributing factors that lead to IE occurrence.</p><p><strong>Results: </strong>The cluster analysis showed that the main contributing factors were the look-alike rocuronium and HepB vaccine packaging, the first-time running HepB vaccination for newborns in the MUH, the lack of a full-time pharmacist, and the unsafe storage of rocuronium and vaccines. The administration of Sugammadex to the newborns followed by their transfer to the neonatal care unit resulted in the recovery of five of the six newborns. Proposed recommendations included (1) raising awareness of healthcare professionals to the risk related to look-alike medications, (2) training nurses to ensure vaccination to implement procedures related to immunization practices, (3) nomination of a full-time pharmacist, (4) reassessment of the safety of drug storage and dispensing at the hospital pharmacy, particularly for high-alert medications.</p><p><strong>Conclusion: </strong>Reporting IEs, particularly serious ones, allows us to identify causes and contributing factors that led to their occurrence. Lessons learned from errors are key to take risk minimization actions to improve vaccine safety worldwide.</p>","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10762870/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Vaccines and Immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25151355231221009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Vaccines are safe and effective, but adverse reactions can occur. Immunization errors (IEs) are one of the types of adverse events following immunization. The Moroccan Pharmacovigilance Centre (MPC) received a cluster of IEs from a maternity university hospital (MUH) regarding six newborns who were inadvertently administered rocuronium instead of hepatitis B (HepB) vaccine. The newborns experienced respiratory distress and one had a fatal outcome.

Objectives: The study aimed to describe the investigation findings, the underlying causes, and contributing factors of the IEs cluster, and proposed risk minimization actions.

Design: We carried out a descriptive analysis of the cluster of IEs related to the HepB vaccine reported to the MPC.

Methods: An investigation was conducted by the Ministry of Health according to the World Health Organization guidance. The root cause analysis was performed to identify underlying causes and contributing factors that lead to IE occurrence.

Results: The cluster analysis showed that the main contributing factors were the look-alike rocuronium and HepB vaccine packaging, the first-time running HepB vaccination for newborns in the MUH, the lack of a full-time pharmacist, and the unsafe storage of rocuronium and vaccines. The administration of Sugammadex to the newborns followed by their transfer to the neonatal care unit resulted in the recovery of five of the six newborns. Proposed recommendations included (1) raising awareness of healthcare professionals to the risk related to look-alike medications, (2) training nurses to ensure vaccination to implement procedures related to immunization practices, (3) nomination of a full-time pharmacist, (4) reassessment of the safety of drug storage and dispensing at the hospital pharmacy, particularly for high-alert medications.

Conclusion: Reporting IEs, particularly serious ones, allows us to identify causes and contributing factors that led to their occurrence. Lessons learned from errors are key to take risk minimization actions to improve vaccine safety worldwide.

从一组新生儿免疫接种错误中汲取教训。
背景:疫苗安全有效,但也可能出现不良反应。免疫接种错误(IEs)是免疫接种后不良反应的一种。摩洛哥药物警戒中心(MPC)从一家大学妇产医院(MUH)收到了一组 IEs,涉及六名新生儿,他们不慎接种了罗库溴铵而非乙肝疫苗(HepB)。这些新生儿出现呼吸窘迫,其中一名新生儿死亡:本研究旨在描述调查结果、IEs 群的根本原因和诱因,以及建议采取的风险最小化行动:我们对向卫生部报告的乙肝疫苗相关 IEs 群进行了描述性分析:方法:卫生部根据世界卫生组织的指导意见开展了一项调查。方法:卫生部根据世界卫生组织的指导意见开展了一项调查,并进行了根本原因分析,以确定导致 IE 发生的根本原因和诱因:聚类分析结果表明,导致 IE 发生的主要因素包括洛库溴铵和乙肝疫苗的包装外观相似、卫生部首次为新生儿接种乙肝疫苗、缺乏专职药剂师以及洛库溴铵和疫苗的储存不安全。给新生儿注射舒降之后转送到新生儿监护室,结果六名新生儿中有五名康复。提出的建议包括:(1)提高医护人员对外观相似药物相关风险的认识;(2)对护士进行培训,以确保接种疫苗时执行免疫接种相关程序;(3)指定一名全职药剂师;(4)重新评估医院药房药物储存和配发的安全性,尤其是高警戒药物:报告 IE,尤其是严重的 IE,可以让我们找出导致其发生的原因和诱因。从错误中吸取的教训是采取风险最小化行动以提高全球疫苗安全性的关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic Advances in Vaccines and Immunotherapy
Therapeutic Advances in Vaccines and Immunotherapy Medicine-Pharmacology (medical)
CiteScore
5.10
自引率
0.00%
发文量
15
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信